Emergent BioSolutions Inc.

By person

30 insiders · 207 transactions

3.9×

Joseph Papa holds only 3.9 times base salary in stock. $4.14M of shares against $1.04M in salary for 2025.

Salary from the company's own proxy. The shares are what Joseph Papa last reported holding, valued at $8.40, the price Common Stock was last bought or sold at on the open market here, on 1 Jul 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

El-Hibri Fuad

Director

—

$62.78M (58)

−$62.78M

10,183,813

19.86%

$85.54M

+37.8%

Abdun-Nabi Daniel

CEO

—

$14.41M (13) scheduled

−$14.41M

144,553

0.2819%

$1.21M

−20.3%

Havey Adam

EVP, Business Operations

—

$10.53M (23) scheduled

−$10.53M

174,398

0.3401%

$1.46M

+323.3%

Kramer Robert

President and CEO

—

$10.12M (5) scheduled

−$10.12M

507,059

0.9889%

$4.26M

+619.3%

Richard Ronald

Director

—

$7.68M (19) scheduled

−$7.68M

123,761

0.2414%

$1.04M

+487.9%

Bailey Sue

Director

—

$4.45M (15)

−$4.45M

24,427

0.0476%

$205.19K

−31.8%

SULLIVAN LOUIS W

Director

—

$4.09M (4) scheduled

−$4.09M

139,098

0.2713%

$1.17M

+288.3%

Harsanyi Zsolt

Chairman

—

$2.74M (6)

−$2.74M

149,076

0.2907%

$1.25M

+316.2%

Zoon Kathryn C

Director

—

$2.19M (26)

−$2.19M

79,941

0.1559%

$671.50K

—

Hauer Jerome M

Director

—

$2.13M (7)

−$2.13M

57,508

0.1122%

$483.07K

+209.4%

JOULWAN GEORGE A

Director

—

$2.04M (6)

−$2.04M

40,244

0.0785%

$338.05K

+82.0%

Kirk Sean

EVP, Manufacturing & Tech Ops

—

$965.64K (3) scheduled

−$965.64K

17,776

0.0347%

$149.32K

+45.9%

DeGolyer Donald W

Director

—

$658.20K (5)

−$658.20K

129,721

0.2530%

$1.09M

—

PAPA JOSEPH C

President and CEO

$349.80K (1)

—

+$349.80K

493,153

0.9618%

$4.14M

—

Glessner Coleen

EVP, Quality & Ethics, and CPL

—

$306.08K (1)

−$306.08K

202,201

0.3944%

$1.70M

—

Fowler Neal Franklin

Director

—

$204.05K (1)

−$204.05K

160,847

0.3137%

$1.35M

—

Dayal Sujata Tyagi

Director

—

$201.13K (3) scheduled

−$201.13K

100,563

0.1961%

$844.73K

—

Katkin Keith

Director

—

$177.60K (2) scheduled

−$177.60K

96,294

0.1878%

$808.87K

—

White Marvin L

Director

—

$171.02K (1)

−$171.02K

113,839

0.2220%

$956.25K

—

LINDAHL RICHARD S

EVP, Chief Financial Officer

$112.38K (1)

—

+$112.38K

374,083

0.7296%

$3.14M

—

Williams Paul Anthony

SVP, Products Business

—

$58.96K (2) scheduled

−$58.96K

159,098

0.3103%

$1.34M

+1,597%

Mulligan Seamus

Director

—

601,731

1.17%

$5.05M

+1.3%

Fox Jennifer Lynne

EVP, Ext Aff, GC, Corp Sec

—

186,382

0.3635%

$1.57M

+2,471%

Hartzel William

SVP, Bioservices

—

185,558

0.3619%

$1.56M

+416.6%

Lowry Simon C

SVP, R&D, CMO

—

177,914

0.3470%

$1.49M

—

Perl Jessica

SVP, General Counsel, Corp Sec

—

165,286

0.3224%

$1.39M

+2,329%

SARAN ATUL

EVP, Chief Strat & Dev Officer

—

86,645

0.1690%

$727.82K

—

Strei Katherine

EVP, Chief HR Officer

—

62,824

0.1225%

$527.72K

+532.0%

FOWLER JOHN D JR

Director

—

30,350

0.0592%

$254.94K

—

Smith Karen L.

EVP, Chief Medical Officer

—

11,888

0.0232%

$99.86K

+88.4%

Individual transactions

Insider

Date

Role

Action

Price

Amount

Williams Paul Anthony

1 Jul 2026

SVP, Products Business

Sold on a plan

3,000

$8.40

$25.20K

Zoon Kathryn C

1 May 2026

Director

Sold on a plan

1,057

$8.97

$9.48K

Zoon Kathryn C

1 May 2026

Director

Sold on a plan

16,145

$8.36

$134.97K

DeGolyer Donald W

1 May 2026

Director

Sold on a plan

954

$8.96

$8.55K

DeGolyer Donald W

1 May 2026

Director

Sold on a plan

14,527

$8.36

$121.45K

Dayal Sujata Tyagi

1 May 2026

Director

Sold on a plan

980

$8.94

$8.76K

Dayal Sujata Tyagi

1 May 2026

Director

Sold on a plan

12,781

$8.36

$106.85K

Katkin Keith

30 Apr 2026

Director

Sold on a plan

15,481

$8.28

$128.18K

Williams Paul Anthony

1 Apr 2026

SVP, Products Business

Sold on a plan

4,000

$8.44

$33.76K

Zoon Kathryn C

15 Aug 2025

Director

Sold on a plan

7,086

$8.87

$62.85K

Katkin Keith

23 May 2025

Director

Sold on a plan

7,844

$6.30

$49.42K

Zoon Kathryn C

2 Jun 2023

Director

Sold on a plan

1,830

$8.35

$15.28K

Zoon Kathryn C

25 May 2023

Director

Sold on a plan

1,700

$8.38

$14.25K

Show all 207 transactions →

Emergent BioSolutions Inc.

By person

Individual transactions

What was left out